14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 10, 2024 Buy 10 000 Hoffmeister David F Common Stock
Apr 10, 2024 Sell 10 000 Hoffmeister David F Stock Option (Right to Buy)
Apr 08, 2024 Buy 59 801 Gilliam Joseph E Common Stock
Apr 08, 2024 Sell 10 456 Gilliam Joseph E Common Stock
Apr 08, 2024 Sell 41 068 Gilliam Joseph E Common Stock
Apr 08, 2024 Sell 8 191 Gilliam Joseph E Common Stock
Apr 08, 2024 Sell 86 Gilliam Joseph E Common Stock
Apr 08, 2024 Sell 59 801 Gilliam Joseph E Stock Option (Right to Buy)
Apr 08, 2024 Sell 145 Thurman Alex R. Common Stock
Apr 08, 2024 Sell 1 227 Thurman Alex R. Common Stock
Apr 05, 2024 Sell 18 Thurman Alex R. Common Stock
Apr 05, 2024 Sell 217 Thurman Alex R. Common Stock
Apr 05, 2024 Sell 27 Thurman Alex R. Common Stock
Apr 05, 2024 Buy 2 457 Gilliam Joseph E Common Stock
Apr 05, 2024 Sell 2 457 Gilliam Joseph E Common Stock
Apr 05, 2024 Sell 2 457 Gilliam Joseph E Stock Option (Right to Buy)
Apr 04, 2024 Buy 200 Gilliam Joseph E Common Stock
Apr 04, 2024 Sell 200 Gilliam Joseph E Common Stock
Apr 04, 2024 Sell 200 Gilliam Joseph E Stock Option (Right to Buy)
Apr 04, 2024 Sell 276 Thurman Alex R. Common Stock
Apr 04, 2024 Sell 158 Thurman Alex R. Common Stock
Apr 03, 2024 Sell 200 Gilliam Joseph E Common Stock
Apr 03, 2024 Sell 200 Gilliam Joseph E Stock Option (Right to Buy)
Apr 03, 2024 Sell 316 Thurman Alex R. Common Stock
Apr 02, 2024 Sell 44 Thurman Alex R. Common Stock
Apr 02, 2024 Sell 170 Thurman Alex R. Common Stock
Apr 02, 2024 Sell 178 Thurman Alex R. Common Stock
Apr 02, 2024 Sell 81 Thurman Alex R. Common Stock
Apr 02, 2024 Sell 1 Thurman Alex R. Common Stock
Apr 01, 2024 Sell 1 001 Thurman Alex R. Common Stock
Apr 01, 2024 Sell 494 Navratil Tomas Common Stock
Apr 01, 2024 Sell 3 907 Burns Thomas William Common Stock
Apr 01, 2024 Sell 1 964 Gilliam Joseph E Common Stock
Apr 01, 2024 Buy 13 721 Gilliam Joseph E Stock Option (Right to Buy)
Mar 28, 2024 Sell 3 808 Burns Thomas William Common Stock
Mar 28, 2024 Sell 2 641 Burns Thomas William Common Stock
Mar 28, 2024 Sell 2 615 Gilliam Joseph E Common Stock
Mar 28, 2024 Sell 4 593 Gilliam Joseph E Common Stock
Mar 28, 2024 Sell 982 Thurman Alex R. Common Stock
Mar 28, 2024 Sell 1 617 Thurman Alex R. Common Stock
Mar 28, 2024 Sell 2 418 Navratil Tomas Common Stock
Mar 28, 2024 Sell 2 603 Navratil Tomas Common Stock
Mar 25, 2024 Sell 459 Navratil Tomas Common Stock
Mar 25, 2024 Sell 1 057 Burns Thomas William Common Stock
Mar 25, 2024 Sell 529 Burns Thomas William Common Stock
Mar 14, 2024 Buy 15 353 Gilliam Joseph E Stock Option (Right to Buy)
Mar 14, 2024 Buy 37 359 Burns Thomas William Stock Option (Right to Buy)
Mar 14, 2024 Buy 8 700 Thurman Alex R. Stock Option (Right to Buy)
Mar 14, 2024 Buy 8 743 Gilliam Joseph E Common Stock
Mar 14, 2024 Buy 3 886 Gilliam Joseph E Common Stock
Mar 14, 2024 Buy 3 660 Gilliam Joseph E Stock Option (Right to Buy)
Mar 14, 2024 Buy 15 161 Gilliam Joseph E Stock Option (Right to Buy)
Mar 14, 2024 Buy 4 955 Thurman Alex R. Common Stock
Mar 14, 2024 Buy 1 830 Thurman Alex R. Stock Option (Right to Buy)
Mar 14, 2024 Buy 8 906 Thurman Alex R. Stock Option (Right to Buy)
Mar 14, 2024 Buy 8 591 Thurman Alex R. Stock Option (Right to Buy)
Mar 14, 2024 Buy 21 275 Burns Thomas William Common Stock
Mar 14, 2024 Buy 15 418 Burns Thomas William Common Stock
Mar 14, 2024 Buy 2 084 Burns Thomas William Common Stock
Mar 14, 2024 Buy 56 404 Burns Thomas William Stock Option (Right to Buy)
Mar 14, 2024 Buy 4 208 Burns Thomas William Stock Option (Right to Buy)
Mar 14, 2024 Buy 36 891 Burns Thomas William Stock Option (Right to Buy)
Mar 14, 2024 Buy 11 075 Navratil Tomas Common Stock
Mar 14, 2024 Buy 1 027 Navratil Tomas Common Stock
Mar 14, 2024 Buy 1 950 Navratil Tomas Common Stock
Mar 07, 2024 Buy 5 000 Kliman Gilbert H Common Stock
Mar 07, 2024 Sell 5 000 Kliman Gilbert H Common Stock
Mar 07, 2024 Sell 5 000 Kliman Gilbert H Stock Option (Right to Buy)
Mar 06, 2024 Sell 3 145 Kliman Gilbert H Common Stock
Mar 06, 2024 Sell 5 202 Kliman Gilbert H Common Stock
Feb 29, 2024 Buy 6 250 Stapley Marc Common Stock
Feb 29, 2024 Sell 2 437 Stapley Marc Common Stock
Feb 29, 2024 Sell 1 500 Stapley Marc Common Stock
Feb 29, 2024 Sell 2 313 Stapley Marc Common Stock
Feb 29, 2024 Sell 6 250 Stapley Marc Stock Option (Right to Buy)
Feb 27, 2024 Sell 8 000 Kliman Gilbert H Common Stock
Feb 23, 2024 Buy 4 607 Gilliam Joseph E Common Stock
Feb 23, 2024 Buy 13 128 Gilliam Joseph E Common Stock
Feb 23, 2024 Buy 74 425 Gilliam Joseph E Common Stock
Feb 23, 2024 Sell 21 414 Gilliam Joseph E Common Stock
Feb 23, 2024 Buy 26 671 Gilliam Joseph E Common Stock
Feb 23, 2024 Sell 114 739 Gilliam Joseph E Common Stock
Feb 23, 2024 Sell 4 092 Gilliam Joseph E Common Stock
Feb 23, 2024 Sell 74 425 Gilliam Joseph E Stock Option (Right to Buy)
Feb 23, 2024 Sell 26 671 Gilliam Joseph E Stock Option (Right to Buy)
Feb 23, 2024 Sell 4 607 Gilliam Joseph E Stock Option (Right to Buy)
Feb 23, 2024 Sell 13 128 Gilliam Joseph E Stock Option (Right to Buy)
Feb 23, 2024 Buy 10 000 Foley Mark J Common Stock
Feb 23, 2024 Sell 4 560 Foley Mark J Common Stock
Feb 23, 2024 Sell 10 000 Foley Mark J Stock Option (Right to Buy)
Feb 12, 2024 Buy 1 512 Gilliam Joseph E Common Stock
Feb 12, 2024 Sell 1 512 Gilliam Joseph E Common Stock
Feb 12, 2024 Sell 1 512 Gilliam Joseph E Stock Option (Right to Buy)
Feb 09, 2024 Buy 631 Gilliam Joseph E Common Stock
Feb 09, 2024 Sell 631 Gilliam Joseph E Common Stock
Feb 09, 2024 Sell 631 Gilliam Joseph E Stock Option (Right to Buy)
Feb 08, 2024 Buy 5 000 Gilliam Joseph E Common Stock
Feb 08, 2024 Sell 5 000 Gilliam Joseph E Common Stock
Feb 08, 2024 Sell 5 000 Gilliam Joseph E Stock Option (Right to Buy)
Jan 02, 2024 Buy 1 044 Stapley Marc Common Stock
INSIDER POWER
0.838
Last 100 transactions
Buy: 501 923 | Sell: 495 631 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.838.

In total, the insiders bought 501 923 and sold 495 631 GKOS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Glaukos Corporation

Glaukos Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stent... GKOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT